# MedInTech raises KRW 33.8B for its INTION S robotic endoscope

*The Korean company announced a KRW 33.8 billion Series C on 17 November 2026, with more investment expected before year-end.*

Published: 2026-11-17 · Segment: In Healthcare

![Product render of the MedInTech INTION S robotic endoscope system, showing a white cart with a monitor displaying a stomach-lining endoscopic image, the processor unit, and the black flexible endoscope, beside the INTION S logo.](https://roboticsdaily.robotshop.com/_astro/medintech-series-c-krw-33-8b-2026-11-17.DMQs6z5w_SYzCw.jpeg)

Image: MedInTech (photo provided by the company), via Venture Square · press-kit

MedInTech, a Korean medical robotics company founded in 2020, announced a KRW 33.8 billion Series C on 17 November 2026, according to Asia Economy. Atinum Investment and KB Investment co-led the round. Existing investors Smilegate Investment, SL Investment, ICF (Nextrans) and Woosin Venture Investment followed on, and K2 Investment Partners joined as a new investor. Cumulative funding is about KRW 62.2 billion.

The round is not closed: the company plans to add more investment before year-end.

Its product, INTION S, is a digestive endoscope driven by motors instead of hand-pulled wires, with AI helping with navigation and lesion tracking. The company also sells INTION DeepEye, AI software that detects and classifies abnormalities in endoscopy images. A 178-adult trial at Seoul National University Hospital found manipulability not inferior to mechanical endoscopes and less physical fatigue for clinicians, with results published in Scientific Reports.

The article does not give the valuation or say where the funds will go.

## Sources

- [Asia Economy](https://view.asiae.co.kr/article/2026111708280565140)

Read this capsule on Robotics Daily: https://roboticsdaily.robotshop.com/capsules/medintech-series-c-krw-33-8b-2026-11-17/
